Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Aug 10, 2016 $2.66 $2.79 $2.63 $2.69 52 000
Aug 09, 2016 $2.70 $2.78 $2.55 $2.67 81 600
Aug 08, 2016 $2.70 $2.70 $2.57 $2.66 54 900
Aug 05, 2016 $2.66 $2.68 $2.54 $2.60 111 500
Aug 04, 2016 $2.81 $2.81 $2.60 $2.70 87 500
Aug 03, 2016 $2.51 $2.74 $2.50 $2.71 259 000
Aug 02, 2016 $2.62 $2.68 $2.48 $2.54 105 500
Aug 01, 2016 $2.72 $2.91 $2.53 $2.65 82 600
Jul 29, 2016 $2.83 $2.85 $2.70 $2.75 109 700
Jul 28, 2016 $2.98 $3.05 $2.80 $2.86 105 800
Jul 27, 2016 $2.69 $3.04 $2.67 $2.89 323 900
Jul 26, 2016 $2.54 $2.68 $2.51 $2.67 169 200
Jul 25, 2016 $2.58 $2.58 $2.50 $2.50 117 900
Jul 22, 2016 $2.50 $2.65 $2.50 $2.55 135 400
Jul 21, 2016 $2.52 $2.64 $2.51 $2.51 87 400
Jul 20, 2016 $2.56 $2.74 $2.51 $2.57 154 000
Jul 19, 2016 $2.57 $2.72 $2.55 $2.59 119 100
Jul 18, 2016 $2.93 $2.98 $2.42 $2.63 551 500
Jul 15, 2016 $3.00 $3.10 $2.68 $2.93 537 400
Jul 14, 2016 $3.34 $3.37 $3.21 $3.29 155 900
Jul 13, 2016 $3.40 $3.40 $3.31 $3.33 80 500
Jul 12, 2016 $3.35 $3.39 $3.30 $3.39 142 700
Jul 11, 2016 $3.35 $3.38 $3.30 $3.34 89 800
Jul 08, 2016 $3.40 $3.43 $3.30 $3.31 110 900
Jul 07, 2016 $3.39 $3.57 $3.27 $3.41 219 800
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT